Lonza

Overview

Swiss CDMO that evolved from a chemical company into a biologics manufacturing powerhouse, cited as a model of CMO partnership maturity and for its capacity-sharing joint venture with Sanofi related to Regeneron products. Lonza evolved from a chemical company barely generating biologics revenue when John Matulsky joined in the late 1990s to a powerhouse CDMO with major cell culture capacity in the US and Singapore, and is cited as an example of a CMO that became a strategic partner rather than a transactional vendor. Lonza entered a significant capacity-sharing joint venture with Sanofi to co-manufacture Regeneron products — an arrangement described as innovative for its time as a model for genuine partnership between a pharma company and its CDMO. (Segment 3 (10:00-15:00))